Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.
about
Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis.Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.Optimizing psychosocial interventions in first-episode psychosis: current perspectives and future directionsEvaluating the effectiveness of a healthy lifestyle clinician in addressing the chronic disease risk behaviours of community mental health clients: study protocol for a randomised controlled trialRandomised controlled trial of a digitally assisted low intensity intervention to promote personal recovery in persisting psychosis: SMART-Therapy study protocol.Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies.Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case reportPharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode.Psychotropic Medication and Substance Use during Pregnancy by Women with Severe Mental Illness.Outcomes following first-episode psychosis - Why we should intervene early in all ages, not only in youth.Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: Data from the Australian Survey of High Impact Psychosis.Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial.An appraisal of practice guidelines for smoking cessation in people with severe mental illness.Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: Outcomes to 36 months.Ventricular volumes across stages of schizophrenia and other psychoses.Raising the standard of care in the treatment of schizophrenia: Yes we can!The treatment of schizophrenia: Can we raise the standard of care?Algorithm-based pharmacotherapy for first-episode schizophrenia involuntarily hospitalized: A retrospective analysis of real-world practice.The Royal Australian and New Zealand College of Psychiatrists guidelines: Acute inpatient care for schizophrenia.Treating body, treating mind: The experiences of people with psychotic disorders and their general practitioners - Findings from the Australian National Survey of High Impact Psychosis.The 2016 RANZCP Guidelines for the Management of Schizophrenia and Related Disorders - what's next?Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness.Commentary on Galletly et al. (2016), The Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.How long will we sleep on obstructive sleep apnoea in schizophrenia?Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014.A stitch in time: 3-monthly long-acting injectable paliperidone palmitate in schizophrenia.Identification of the delivery of cognitive behavioural therapy for psychosis (CBTp) using a cross-sectional sample from electronic health records and open-text information in a large UK-based mental health case register.Participation in mental healthcare: a qualitative meta-synthesis.Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk.Using 'WeChat' online social networking in a real-world needs analysis of family members of youths at clinical high risk of psychosis.Addiction Vulnerability: Exploring Relationships Between Cigarette Smoking, Substance Misuse and Early Psychosis.Antipsychotic polypharmacy in older Australians.Severity of illness and adaptive functioning predict quality of care of children among parents with psychosis: A confirmatory factor analysis.Compliance of metabolic monitoring at rehabilitation facilities.Enduring themes across journal issues.Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.The imperative to screen for obstructive sleep apnoea in people with schizophrenia.Embedding exercise interventions as routine mental health care: implementation strategies in residential, inpatient and community settings.
P2860
Q30240167-128CC491-B6C3-4C11-B81E-C3E980B9F086Q33560808-06F82CE5-7293-4865-A601-B66DDB79E47EQ33631663-2A9D6507-FF51-413C-B5B8-6FC2E66E8D32Q33805482-F8FC0AC3-C6ED-44D8-9224-5B5983A0BB29Q36125663-4D791CD1-D28F-48A9-BD92-F1750E58EF1CQ36348922-208C76BD-2057-4E78-B527-A8A2F49341A8Q37233407-7C1B6FD9-D508-4AE0-AA1C-2A15C3D2F135Q37576827-2B80BD1B-D908-4340-A3FF-7B23DB7F7A4DQ37647623-D75CA9D0-9F94-4B08-A8B6-41CA657DE61CQ37652248-B3BC9242-3F5D-40B9-9A01-FED57BAB2B72Q38614504-FF812466-83D2-4ECB-9003-388DF2EBBCF5Q38625817-7BC1FAD9-79DB-4ED8-8B3A-FE2B65AED367Q38634848-32D05080-3B00-4C74-AF78-C06D0DCF8E56Q38671397-BB292212-C27F-45CB-AEE6-760DED4AB7EAQ38697215-DF76AACC-672B-47E3-B001-13F92F64F6CCQ38856821-CDA9FDC7-63D6-4907-9983-4ECF11959529Q39002140-043E56FC-D83A-43FC-B60F-E0D4087950B5Q39317506-044E12F1-8CB6-4578-91D0-B4CDBC42EF34Q39408357-BE9D8789-ABFC-4CAA-8409-4369FE4D101DQ40048227-A6DDE825-48A3-4C48-89AA-4ED76C198A36Q40056442-7F52D29E-CB6B-4B22-8EDB-09121EDFBF2BQ40082921-D4647C75-8EE6-4F4E-9672-1AB27E56B371Q40273385-11AF9D99-ECCF-4C97-836D-BF49606BA610Q40498326-22D6314B-66E1-42A7-B79C-FC3549E949A5Q40617480-E2197A0F-BEC6-4FAE-8E3C-2AD5F3235FFFQ41582083-7693F65D-CBF6-4B35-8D71-519AE74CD0B0Q42361294-542CFBFF-A9B8-4AEE-80FC-CEFA0B4C1522Q47120615-290727EE-CE1A-4770-9E1D-54464072A788Q47136944-63B9EDE6-BA4A-4F75-B03E-91E0909642E1Q47152270-A684D4BB-C7CB-4D13-AF1B-10A43183FBC6Q47197810-361CB6B4-4431-429B-8C60-0C32F12F4BE0Q47353700-546A1455-B5B2-4C2A-A6D1-52D4CBC68290Q47562372-DDCCAD6B-CDDE-4DFA-94D9-F22216D2F90CQ47576672-3070CA18-6E0D-4D72-802E-5F6D01305182Q47581004-8EA9D130-ED87-4389-8771-47407FF421BEQ47585281-137EDBA3-657E-43C1-83A5-9284F12F8F5AQ47640761-EDD8FED8-4467-449B-A46C-88C4BA63B450Q47645310-27450967-8ECA-4D59-BE5F-8E077ECA779AQ47688725-916DCC69-0D7A-47B2-8434-FCE12C03F550Q47702372-6F40BA27-8175-4EA1-B5DF-18540B7DBCD4
P2860
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Royal Australian and New Zeala ...... phrenia and related disorders.
@en
type
label
Royal Australian and New Zeala ...... phrenia and related disorders.
@en
prefLabel
Royal Australian and New Zeala ...... phrenia and related disorders.
@en
P2093
P2860
P356
P1476
Royal Australian and New Zeala ...... phrenia and related disorders.
@en
P2093
Assen Jablensky
Cherrie Galletly
David Castle
Eóin Killackey
Frances Dark
Jayashri Kulkarni
Patrick McGorry
Verity Humberstone
P2860
P304
P356
10.1177/0004867416641195
P577
2016-05-01T00:00:00Z